[F1 PART 12A U.K. Sale of medicines to the public at a distance

Textual Amendments

F1 Pt. 12A inserted (coming into force in accordance with reg. 1(2) of the amending S.I.) by The Human Medicines (Amendment) Regulations 2013 (S.I. 2013/1855), regs. 1(2), 28

Grant or refusal to list a person U.K.

256G.— (1) On receipt of a notification from a person to be included in the list—

(a) the competent authority of a member State must include that person on the list if that person complies with the requirements in regulation 256C(2) to (5); or

(b) if it considers necessary or appropriate to do so, the competent authority of a member State must refuse to include that person on the list having had regard to—

(i) the provisions of these Regulations, and

(ii) any EU obligation.

(2) The competent authority of a member State must give a notice stating the reasons for its decision in any case where that competent authority—

(a) refuses to include a person on the list; or

(b) includes a person in the list otherwise than in accordance with the notification and that person requests a statement of its reasons.

(3) Where the competent authority of a member State decides to include a person on the list that competent authority must ensure that the relevant website of the member State includes—

(a) the name or corporate name of the person that is listed; and

(b) the person’s website address in the United Kingdom.]